Diretrizes internacionais

Reino Unido

Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over

Publicada por:National Institute for Health and Care Excellence

Última publicação:2022

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

Publicada por:Nerve Tumours UK (formerly Neurofibromatosis Association)

Última publicação:2007

Europa

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

Publicada por:Neurofibromatosis France Network

Última publicação:2020

América do Norte

Care of adults with neurofibromatosis type 1: a clinical practice resource

Publicada por:American College of Medical Genetics and Genomics (ACMG)

Última publicação:2018

Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1

Publicada por:American Association of Cancer Research

Última publicação:2017

Restante do mundo

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Publicada por:International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC)

Última publicação:2021

O uso deste conteúdo está sujeito ao nosso aviso legal